Abbott Laboratories

/Abbott Laboratories
27 07, 2016

Abbott Cell-Dyn 1800 – A Perfect Size Analyzer for Any Hematology Lab

By |July 27th, 2016|Abbott Laboratories, Hematology Analyzers|Comments Off on Abbott Cell-Dyn 1800 – A Perfect Size Analyzer for Any Hematology Lab

Automated hematology analyzers available now provide new additional parameters, enabling earlier and more precise diagnosis. The Cell-Dyn 1800 manufactured by Abbott Laboratories is an automated hematology analyzer that provides an 18-parameter blood count and operates at a throughput of 60 specimens per hour. The device provides fast, accurate results and differential screening in a compact, [...]

12 02, 2016

Abbott Acquires Alere to Gain Leadership in Point-of-care Segment

By |February 12th, 2016|Abbott Laboratories, Alere|Comments Off on Abbott Acquires Alere to Gain Leadership in Point-of-care Segment

Abbott Laboratories has reached an agreement to acquire Alere Inc for $5.8 billion. In a press release, Abbott said that once the transaction is completed, it will become the leading diagnostics provider of point of care testing. Alere's complementary technologies will help Abbott provide better care for patients by meeting the growing demand for fast, [...]

11 12, 2015

Abbott i-STAT Improves Clinical Decision Making – Finds European Study

By |December 11th, 2015|Abbott i-STAT, Abbott Laboratories|Comments Off on Abbott i-STAT Improves Clinical Decision Making – Finds European Study

Abbott’s i-STAT, a portable blood clinical analyzer, has been found to improve decision making in healthcare settings. Data presented at the European Society for Emergency Medicine (EuSEM) Congress held in October 2015 in Italy confirmed that the i-STAT handheld analyzer has the capability to provide clinicians with the information needed for quick decision making, thereby [...]

31 08, 2015

Blood Processing Devices and Consumables Market to Grow to $49 Billion by 2019

By |August 31st, 2015|Abbott Laboratories, Blood Collection|Comments Off on Blood Processing Devices and Consumables Market to Grow to $49 Billion by 2019

Blood processing devices and consumables are essential in the healthcare industry with new blood-related disorders and infections emerging day by day. Blood transfusion is a regular procedure in hospitals, which requires these products. Unsafe blood transfusion can lead to the spread of dangerous diseases. With the high prevalence of infectious diseases such as hepatitis and [...]

20 05, 2015

Global Lab Accessories Market Forecast to 2020

By |May 20th, 2015|Abbott Laboratories, Global Lab Accessories Market|Comments Off on Global Lab Accessories Market Forecast to 2020

Laboratories require high quality equipment to deliver accurate, consistent and quick results. With more and more hospitals and research institutes choosing to automate their testing laboratories, demand for laboratory accessories is set to rise in the near future, says a recent report from Markets and Markets. A survey conducted by the editors of Laboratory Equipment [...]

16 02, 2015

Study: Global Cancer Biomarkers Market to Grow at CAGR of 18.26% During 2014-19

By |February 16th, 2015|Abbott Laboratories, Beckman Coulter|Comments Off on Study: Global Cancer Biomarkers Market to Grow at CAGR of 18.26% During 2014-19

With the increased prevalence of cancer, the tools to detect this deadly disease are also in great demand. Cancer biomarkers are molecules secreted by a tumor or a specific response of the body to the presence of cancer. They are non-invasive, enable high speed cancer diagnosis and also enhance early cancer detection and screening. PSA [...]

10 02, 2015

Abbott Acquires Exclusive Right for Bladder Cancer Biomarker FGFR3

By |February 10th, 2015|Abbott Laboratories|Comments Off on Abbott Acquires Exclusive Right for Bladder Cancer Biomarker FGFR3

Biomarkers used in cancer diagnostics speed up the process significantly and enhance the quality of early stage cancer detection and screening. Abbot Laboratories, a leader in the cancer biomarker market, has acquired exclusive rights for FGFR3 gene mutations for use in detecting bladder cancer. Developed at Institut Curie, the FGFR3 gene mutation is useful for [...]

4 10, 2014

Importance of HIV and HCV Testing During Pregnancy

By |October 4th, 2014|Abbott Laboratories|Comments Off on Importance of HIV and HCV Testing During Pregnancy

Vertical transmission is becoming the leading source of infection for those individuals, especially pregnant women who have never been tested for the presence of human immunodeficiency virus (HIV) or hepatitis C virus (HCV) in their blood. According to CDC, almost one in six (15.8%) people in the U.S with this disease are unaware of their [...]

25 09, 2014

Growing Importance of Diagnosis at the Point of Care

By |September 25th, 2014|Abbott Laboratories, Point of Care Analyzers|Comments Off on Growing Importance of Diagnosis at the Point of Care

The development of portable diagnostic point of care analyzers and other monitoring devices has resulted in timely, rapid treatment to the patient. These self-contained devices allow diagnoses to be made in the physician's office, the home, an ambulance, in the hospital, and other settings. Patients no longer have to wait hours or even days for [...]

22 08, 2014

Need for New Infant HIV-1 Prevention Methods Stressed

By |August 22nd, 2014|Abbott Laboratories, Alere|Comments Off on Need for New Infant HIV-1 Prevention Methods Stressed

The number of children infected with HIV has risen dramatically in developing countries. Symptoms of the infection in children include recurrent fungal infections, growth failure and behavioral abnormalities. Antibody testing is the most commonly used method to diagnose HIV infection. According to the Joint United Nations Program on HIV/AIDS (UNAIDS), an estimated 1,000 babies are [...]